Author: C. Terrance Hawk
Publisher: Wiley-Blackwell
ISBN: 9780813810485
Category : Medical
Languages : en
Pages : 203
Book Description
Formulary for Laboratory Animals is an invaluable reference for treatment of laboratory animals and pocket pets. Drugs are listed alphabetically and categorized in five sections based on pharmacologic activity and animal species. This at-a-glance pocket reference is valuable for students and practitioners of veterinary medicine, researchers and laboratory technicians who prescribe or administer drugs used on common laboratory animals. The third edition includes a stronger international component, coverage of several new drugs, hundreds of additional dosages, and a thorough update throughout based on the most current research. The third edition also includes a chapter describing how to estimate drug dosages among species using allometric scaling methodology.
Formulary for Laboratory Animals
Author: C. Terrance Hawk
Publisher: Wiley-Blackwell
ISBN: 9780813810485
Category : Medical
Languages : en
Pages : 203
Book Description
Formulary for Laboratory Animals is an invaluable reference for treatment of laboratory animals and pocket pets. Drugs are listed alphabetically and categorized in five sections based on pharmacologic activity and animal species. This at-a-glance pocket reference is valuable for students and practitioners of veterinary medicine, researchers and laboratory technicians who prescribe or administer drugs used on common laboratory animals. The third edition includes a stronger international component, coverage of several new drugs, hundreds of additional dosages, and a thorough update throughout based on the most current research. The third edition also includes a chapter describing how to estimate drug dosages among species using allometric scaling methodology.
Publisher: Wiley-Blackwell
ISBN: 9780813810485
Category : Medical
Languages : en
Pages : 203
Book Description
Formulary for Laboratory Animals is an invaluable reference for treatment of laboratory animals and pocket pets. Drugs are listed alphabetically and categorized in five sections based on pharmacologic activity and animal species. This at-a-glance pocket reference is valuable for students and practitioners of veterinary medicine, researchers and laboratory technicians who prescribe or administer drugs used on common laboratory animals. The third edition includes a stronger international component, coverage of several new drugs, hundreds of additional dosages, and a thorough update throughout based on the most current research. The third edition also includes a chapter describing how to estimate drug dosages among species using allometric scaling methodology.
VA Drug Formulary
Author: United States. General Accounting Office
Publisher:
ISBN:
Category : Drugs
Languages : en
Pages : 42
Book Description
Publisher:
ISBN:
Category : Drugs
Languages : en
Pages : 42
Book Description
Combating Tobacco Use in Military and Veteran Populations
Author: Institute of Medicine
Publisher: National Academies Press
ISBN: 0309146844
Category : Medical
Languages : en
Pages : 381
Book Description
The health and economic costs of tobacco use in military and veteran populations are high. In 2007, the Department of Veterans Affairs (VA) and the Department of Defense (DoD) requested that the Institute of Medicine (IOM) make recommendations on how to reduce tobacco initiation and encourage cessation in both military and veteran populations. In its 2009 report, Combating Tobacco in Military and Veteran Populations, the authoring committee concludes that to prevent tobacco initiation and encourage cessation, both DoD and VA should implement comprehensive tobacco-control programs.
Publisher: National Academies Press
ISBN: 0309146844
Category : Medical
Languages : en
Pages : 381
Book Description
The health and economic costs of tobacco use in military and veteran populations are high. In 2007, the Department of Veterans Affairs (VA) and the Department of Defense (DoD) requested that the Institute of Medicine (IOM) make recommendations on how to reduce tobacco initiation and encourage cessation in both military and veteran populations. In its 2009 report, Combating Tobacco in Military and Veteran Populations, the authoring committee concludes that to prevent tobacco initiation and encourage cessation, both DoD and VA should implement comprehensive tobacco-control programs.
VA Drug Formulary
Author: John E. Dicken
Publisher: DIANE Publishing
ISBN: 1437938809
Category : Technology & Engineering
Languages : en
Pages : 41
Book Description
This is a print on demand edition of a hard to find publication. In 2009, VA spent nearly $4 billion on prescriptions for vets. In general, VA provides drugs on its national formulary. However, all VA medical centers must have a non-formulary drug request process that is overseen by their regional Veterans Integrated Service Network (VISN). This report reviewed: (1) the process VA uses to review drugs for its national formulary; (2) the approaches VISNs and medical centers take to implementing the non-formulary drug request process; (3) the extent to which VA ensures the timely adjudication of non-formulary drug requests; and (4) the mechanisms VA has in place to obtain beneficiary input on the national formulary and make the drug review process transparent. Includes recommendations. Charts and tables.
Publisher: DIANE Publishing
ISBN: 1437938809
Category : Technology & Engineering
Languages : en
Pages : 41
Book Description
This is a print on demand edition of a hard to find publication. In 2009, VA spent nearly $4 billion on prescriptions for vets. In general, VA provides drugs on its national formulary. However, all VA medical centers must have a non-formulary drug request process that is overseen by their regional Veterans Integrated Service Network (VISN). This report reviewed: (1) the process VA uses to review drugs for its national formulary; (2) the approaches VISNs and medical centers take to implementing the non-formulary drug request process; (3) the extent to which VA ensures the timely adjudication of non-formulary drug requests; and (4) the mechanisms VA has in place to obtain beneficiary input on the national formulary and make the drug review process transparent. Includes recommendations. Charts and tables.
Oxford Handbook of Clinical Pharmacy
Author: Phil Wiffen
Publisher: Oxford University Press, USA
ISBN: 0199603642
Category : Medical
Languages : en
Pages : 696
Book Description
This handbook is the definitive quick reference guide to clinical pharmacy, providing practising and student pharmacists with a wealth of practical information.
Publisher: Oxford University Press, USA
ISBN: 0199603642
Category : Medical
Languages : en
Pages : 696
Book Description
This handbook is the definitive quick reference guide to clinical pharmacy, providing practising and student pharmacists with a wealth of practical information.
Medications for Opioid Use Disorder Save Lives
Author: National Academies of Sciences, Engineering, and Medicine
Publisher: National Academies Press
ISBN: 0309486483
Category : Medical
Languages : en
Pages : 175
Book Description
The opioid crisis in the United States has come about because of excessive use of these drugs for both legal and illicit purposes and unprecedented levels of consequent opioid use disorder (OUD). More than 2 million people in the United States are estimated to have OUD, which is caused by prolonged use of prescription opioids, heroin, or other illicit opioids. OUD is a life-threatening condition associated with a 20-fold greater risk of early death due to overdose, infectious diseases, trauma, and suicide. Mortality related to OUD continues to escalate as this public health crisis gathers momentum across the country, with opioid overdoses killing more than 47,000 people in 2017 in the United States. Efforts to date have made no real headway in stemming this crisis, in large part because tools that already existâ€"like evidence-based medicationsâ€"are not being deployed to maximum impact. To support the dissemination of accurate patient-focused information about treatments for addiction, and to help provide scientific solutions to the current opioid crisis, this report studies the evidence base on medication assisted treatment (MAT) for OUD. It examines available evidence on the range of parameters and circumstances in which MAT can be effectively delivered and identifies additional research needed.
Publisher: National Academies Press
ISBN: 0309486483
Category : Medical
Languages : en
Pages : 175
Book Description
The opioid crisis in the United States has come about because of excessive use of these drugs for both legal and illicit purposes and unprecedented levels of consequent opioid use disorder (OUD). More than 2 million people in the United States are estimated to have OUD, which is caused by prolonged use of prescription opioids, heroin, or other illicit opioids. OUD is a life-threatening condition associated with a 20-fold greater risk of early death due to overdose, infectious diseases, trauma, and suicide. Mortality related to OUD continues to escalate as this public health crisis gathers momentum across the country, with opioid overdoses killing more than 47,000 people in 2017 in the United States. Efforts to date have made no real headway in stemming this crisis, in large part because tools that already existâ€"like evidence-based medicationsâ€"are not being deployed to maximum impact. To support the dissemination of accurate patient-focused information about treatments for addiction, and to help provide scientific solutions to the current opioid crisis, this report studies the evidence base on medication assisted treatment (MAT) for OUD. It examines available evidence on the range of parameters and circumstances in which MAT can be effectively delivered and identifies additional research needed.
FDA Approved Animal Drug Products
Author:
Publisher:
ISBN:
Category : Veterinary drugs
Languages : en
Pages : 144
Book Description
Publisher:
ISBN:
Category : Veterinary drugs
Languages : en
Pages : 144
Book Description
MDS-3
Author: Martha A. Embrey
Publisher:
ISBN: 9781565495876
Category : Drugs
Languages : en
Pages : 0
Book Description
Managing Drug Supply (MDS) is the leading reference on how to manage essential medicines in developing countries. MDS was originally published in 1982; it was revised in 1997 with over 10,000 copies distributed in over 60 countries worldwide. The third edition, MDS-3: Managing Access to Medicines and Health Technologies reflects the dramatic changes in politics and public health priorities, advances in science and medicine, greater focus on health care systems, increased donor funding, and the advent of information technology that have profoundly affected access to essential medicines over the past 14 years. Nearly 100 experts from a wide range of disciplines and virtually every corner of the world have contributed to this third edition. In addition to many new country studies, references, and extensive revisions, MDS-3 offers new chapters on areas such as pharmaceutical benefits in insurance programs, pricing, intellectual property, drug seller initiatives, and traditional and complementary medicine. The revisions and new chapters echo the wide variety of issues that are important to health practitioners and policy makers today. MDS-3 will be a valuable tool in the effort to ensure universal access to quality medicines and health technologies and their appropriate use.
Publisher:
ISBN: 9781565495876
Category : Drugs
Languages : en
Pages : 0
Book Description
Managing Drug Supply (MDS) is the leading reference on how to manage essential medicines in developing countries. MDS was originally published in 1982; it was revised in 1997 with over 10,000 copies distributed in over 60 countries worldwide. The third edition, MDS-3: Managing Access to Medicines and Health Technologies reflects the dramatic changes in politics and public health priorities, advances in science and medicine, greater focus on health care systems, increased donor funding, and the advent of information technology that have profoundly affected access to essential medicines over the past 14 years. Nearly 100 experts from a wide range of disciplines and virtually every corner of the world have contributed to this third edition. In addition to many new country studies, references, and extensive revisions, MDS-3 offers new chapters on areas such as pharmaceutical benefits in insurance programs, pricing, intellectual property, drug seller initiatives, and traditional and complementary medicine. The revisions and new chapters echo the wide variety of issues that are important to health practitioners and policy makers today. MDS-3 will be a valuable tool in the effort to ensure universal access to quality medicines and health technologies and their appropriate use.
Advances in Patient Safety
Author: Kerm Henriksen
Publisher:
ISBN:
Category : Medical
Languages : en
Pages : 526
Book Description
v. 1. Research findings -- v. 2. Concepts and methodology -- v. 3. Implementation issues -- v. 4. Programs, tools and products.
Publisher:
ISBN:
Category : Medical
Languages : en
Pages : 526
Book Description
v. 1. Research findings -- v. 2. Concepts and methodology -- v. 3. Implementation issues -- v. 4. Programs, tools and products.
Agent Orange Review
Author:
Publisher:
ISBN:
Category : Agent Orange
Languages : en
Pages : 8
Book Description
Publisher:
ISBN:
Category : Agent Orange
Languages : en
Pages : 8
Book Description